Physician Assistant, Surgical · North Dartmouth, MA
NPI
1265491807
Since 2006
Specialty
Physician Assistant, Surgical
Code 363AS0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
300a Faunce Corner Rd
North Dartmouth, MA, 02747
Phone (508) 973-9050
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
1,525 services
Medicare patients, 2024
471
Average age 69
Drug cost, 2024
$1.9M
5,617 prescriptions
Company payments, 2025
$858
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anargyros T Skaliotis was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 590 times for 387 patients. In total Anargyros T Skaliotis billed 1,525 services in 13 codes, and Medicare paid $83K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-06-06.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 590 | 387 | $11.45 | $6,758 |
| 99214 Office E&M - Established | Office | 567 | 381 | $84.48 | $48K |
| 99215 Office E&M - Established | Office | 227 | 201 | $120.46 | $27K |
By year: 2022 $155K for 2,695 services; 2023 $95K for 1,303 services; 2024 $83K for 1,525 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 39 | $8.40 | $361 |
| 87428 Infectious Agent Detection by DNA/RNA | 16 | 16 | $30.32 | $485 |
| 83036 Blood Count | 15 | 15 | $9.52 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Anargyros T Skaliotis prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 717 prescriptions and refills. In total Anargyros T Skaliotis wrote 5,617 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 717 | 832 | 186 | $24K |
| Ventolin Hfa Albuterol Sulfate | 450 | 469 | 91 | $28K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 431 | 539 | 73 | $336K |
| Prednisone Generic | 273 | 326 | 100 | $1,451 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 273 | 315 | 57 | $195K |
| Montelukast Sodium Generic | 237 | 592 | 70 | $3,865 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 214 | 256 | 38 | $123K |
| Breo Ellipta Fluticasone/Vilanterol | 189 | 250 | 41 | $97K |
| Incruse Ellipta Umeclidinium Bromide | 177 | 223 | 30 | $74K |
| Symbicort Budesonide/Formoterol Fumarate | 145 | 207 | 46 | $47K |
| Spiriva Respimat Tiotropium Bromide | 135 | 209 | 33 | $109K |
| Azithromycin Generic | 128 | 138 | 49 | $1,015 |
| Fluticasone Propionate Generic | 119 | 238 | 40 | $2,268 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 102 | 118 | 22 | $53K |
| Omeprazole Generic | 98 | 221 | 47 | $1,683 |
Brand drugs: 3,405 claims; generic drugs: 2,197 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anargyros T Skaliotis $858 ($858 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $461.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 19 | $461 |
| Electromed, Inc. ELMD | 4 | $77.04 |
| Viatris Specialty LLC | 2 | $39.71 |
| GlaxoSmithKline, LLC. GSK | 2 | $35.1 |
| Grifols USA, LLC | 1 | $34.82 |
| Verona Pharma, Inc. VRNA | 1 | $30.6 |
| United Therapeutics Corporation UTHR | 1 | $26.65 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26.37 |
| Genentech USA, Inc. ROG.SW | 1 | $23.03 |
| Genzyme Corporation SNY | 1 | $23.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.